Skip to main navigation Skip to search Skip to main content

Anti-CTLA-4 Probody BMS-986249 Alone or in Combination with Nivolumab in Patients with Advanced Cancers: Initial Phase I Results.

  • Bruno Bastos

Research output: Contribution to conference › Presentation

Original languageAmerican English
StatePublished - 2020
Event2020 ASCO Annual Meeting -
Duration: Jan 1 2020 → …

Conference

Conference2020 ASCO Annual Meeting
Period1/1/20 → …

Disciplines

  • Medicine and Health Sciences

Cite this